相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。TMPRSS2: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
F. Demichelis et al.
ONCOGENE (2007)
Expression signatures that correlated with Gleason score and relapse in prostate cancer
Marina Bibikova et al.
GENOMICS (2007)
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24
Meredith Yeager et al.
NATURE GENETICS (2007)
Multiple regions within 8q24 independently affect risk for prostate cancer
Christopher A. Haiman et al.
NATURE GENETICS (2007)
Two common chromosome 8q24 variants are associated with increased risk for prostate cancer
Liang Wang et al.
CANCER RESEARCH (2007)
A common 8q24 variant in prostate and breast cancer from a large nested case-control study
Fredrick R. Schumacher et al.
CANCER RESEARCH (2007)
Stratification of patient risk based on prostate-specific antigen doubling time after radical retropubic prostatectomy
Matthew K. Tollefson et al.
MAYO CLINIC PROCEEDINGS (2007)
Optimization of laser capture microdissection and RNA amplification for gene expression profiling of prostate cancer
Dagmar M. Kube et al.
BMC MOLECULAR BIOLOGY (2007)
The common variant rs1447295 on chromosome 8q24 and prostate cancer risk: Results from an Australian population-based case-control study
Gianluca Severi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Integrative molecular concept modeling of prostate cancer progression
Scott A. Tomlins et al.
NATURE GENETICS (2007)
Concordance among gene-expression-based predictors for breast cancer
Cheng Fan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Overexpression of EIFS3 promotes cancer cell growth
Kimmo J. Savinainen et al.
PROSTATE (2006)
A common variant associated with prostate cancer in European and African populations
Laufey T. Amundadottir et al.
NATURE GENETICS (2006)
TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer
SA Tomlins et al.
CANCER RESEARCH (2006)
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins et al.
SCIENCE (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy
DA Patel et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer
GV Glinsky et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer
KJ Savinainen et al.
BRITISH JOURNAL OF CANCER (2004)
Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy
JW Moul et al.
JOURNAL OF UROLOGY (2004)
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
J Lapointe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Potential survival advantage with early androgen deprivation for biochemical failure after external beam radiotherapy: The importance of accurately defining biochemical disease status
LL Kestin et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy
YP Yu et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Gene expression profiles in formalin-fixed, paraffin-embedded tissues obtained with a novel assay for microarray analysis
M Bibikova et al.
CLINICAL CHEMISTRY (2004)
Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression
DR Rhodes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Quantitative gene expression profiling in formalin-fixed, paraffin-embedded tissues using universal bead arrays
M Bibikova et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Faster cyclic loess: normalizing RNA arrays via linear models
KV Ballman et al.
BIOINFORMATICS (2004)
ONCOMINE: A cancer microarray database and integrated data-mining platform
DR Rhodes et al.
NEOPLASIA (2004)
RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer
KP Porkka et al.
GENES CHROMOSOMES & CANCER (2004)
Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era
AV D'Amico et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Validation of a treatment policy for patients with prostate specific antigen failure after three-dimensional conformal prostate radiation therapy
WH Pinover et al.
CANCER (2003)
Determinants of prostate cancer-specific survival after radiation therapy for patients with clinically localized prostate cancer
AV D'Amico et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer
N Tsuchiya et al.
GENES CHROMOSOMES & CANCER (2002)
Mapping and gene expression profile of the minimally overrepresented 8q24 region in prostate cancer
N Tsuchiya et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Gene expression correlates of clinical prostate cancer behavior
D Singh et al.
CANCER CELL (2002)
Amplification of EIF3S3 gene is associated with advanced stage in prostate cancer
O Saramaki et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Delineation of prognostic biomarkers in prostate cancer
SM Dhanasekaran et al.
NATURE (2001)
Phase III Radiation Therapy Oncology Group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate
MV Pilepich et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy: Biochemical and pathological effects
ME Gleave et al.
JOURNAL OF UROLOGY (2001)
Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate
CA Lawton et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
Overall survival after prostate-specific-antigen-detected recurrence following conformal radiation therapy
HM Sandler et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: Continued rise of biochemical failure after 5 years
CL Amling et al.
JOURNAL OF UROLOGY (2000)
Prostate specific antigen only progression of prostate cancer
JW Moul
JOURNAL OF UROLOGY (2000)
分享论文
